British Journal of Medicine and Medical Research, ISSN: 2231-0614,Vol.: 11, Issue.: 8
Deconstructing Medicine: The Alternative Cellular Energy Pathway
W. John Martin1* 1Institute of Progressive Medicine, South Pasadena, California, USA.
W. John Martin1*
1Institute of Progressive Medicine, South Pasadena, California, USA.
(1) Shashank Kumar, Department of Biochemistry, University of Allahabad, Allahabad, India.
(1) Sema Kalkan Uçar, Ege University, Turkey.
(2) Bhaskar Sharma, Suresh Gyan Vihar University, Rajasthan, India.
Complete Peer review History: http://sciencedomain.org/review-history/11851
The pharmaceutical model for treating chronic illnesses has largely dominated the practice of medicine since the Flexner report of 1910. It essentially entails biochemical based endeavors to correct detectable or discerned metabolic imbalances in diseased cells. These manipulations almost invariably alter the metabolism of normal cells leading to predictable adverse side effects. Enhancing cellular energy can potentially help overcome cellular impairments in diseased cells without necessarily affecting normal cells. The identification of the alternative cellular energy (ACE) pathway, expressed as a dynamic (kinetic) quality of biological fluids, is providing a useful new paradigm for universally applicable therapeutic endeavors. This article reviews the current understanding of the fluid activation process. It appears to be mediated by a repulsive environmental force termed KELEA (kinetic energy limiting electrostatic attraction), which reduces the strength of intermolecular hydrogen bonding. Various means of imparting KELEA to drinking water are discussed. The article is intended to encourage widespread clinical evaluation of KELEA activated “ACE Water” as a waterceuticalÔ in the prevention and therapy of many clinical illnesses.
KELEA; alternative cellular energy; ACE Pathway; ACE water; waterceuticalTM; enerceuticalTM; stealth adapted viruses; energy medicine; chronic illnesses.
Full Article - PDF Page 1-6
DOI : 10.9734/BJMMR/2016/21484Review History Comments